Skip to main content

US ClosedU.S. Closed

IBIO: iBio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

iBio, Inc. , a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients.

52W Range

19thpctl

Volume

0.56×avg

Market Cap

21.47MUSD

P/E Ratio

-4.2TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

iBio, Inc.

IBIONASDAQ Capital Market·USD·Closed

iBio, Inc.

IBIONASDAQ·USD·Closed

$1.36

−2.86%

$1.36

−$0.04 (2.86%)

52W Range

19thpctl

Volume

0.56×avg

Mkt Cap

21.47MUSD

P/E

-4.2TTM

Div Yield

–ann